期刊文献+

实时荧光定量PCR检测淋巴细胞中NKG2D、穿孔素和颗粒酶B基因的表达 被引量:2

The quantitative detection of NKG2D,perforin and granzyme B gene expressions in lymphocytes by SYBR green Ⅰ real-time fluorescence quantitative PCR
下载PDF
导出
摘要 目的:建立可用于测定淋巴细胞免疫功能的SYBRGreen I实时荧光定量PCR技术。方法:根据NCBI基因库中4种基因(NKG2D、穿孔素、颗粒酶B和内参照GAPDH)的序列,设计合成相应的引物,扩增上述基因。建立SYBRGreen I实时荧光定量PCR方法,检测肿瘤患者外周血淋巴细胞和诱导培养的患者CIK细胞(cytokine induced killer,CIK)中NKG2D、穿孔素和颗粒酶B mRNA的含量。结果:应用设计的引物扩增NKG2D、穿孔素和颗粒酶B基因后,经琼脂糖凝胶电泳和溶解曲线分析表明具有特异性。SYBR Green I实时荧光定量PCR检测结果表明,肿瘤患者的淋巴细胞中颗粒酶B基因的表达降低,而经细胞因子和单克隆抗体诱导培养的肿瘤患者CIK细胞与其淋巴细胞相比,细胞中穿孔素和颗粒酶B基因的表达明显增加(P<0.01)。结论:该SYBRGreen I实时荧光定量PCR方法可用于检测淋巴细胞中NKG2D、穿孔素和颗粒酶B的mRNA的表达、作为研究淋巴细胞免疫功能的有力手段。 AIM: To develop a SYBR Green I real-time fluorescence quantitative PCR for the detection of lymphocyte immune function.METHODS: The primers of NKG2D,perforin,granzyme B and keeping-home gene GAPDH were designed and synthesized according to NCBI gene sequences,and the real-time fluorescence quantitative PCR was established.The gene expressions of NKG2D,perforin and granzyme B in lymphocytes from cancer patients and CIK induced from the cancer patients lymphocytes in vitro were quantified by real-time fluorescence quantitative PCR.RESULTS: NKG2D,perforin and granzyme B mRNA could be specifically amplified and quantitatively detected by the SYBR Green I real-time fluorescence quantitative PCR according to agarose gel electrophoresis and melt curve analysis.The mRNA expression of granzyme B was reduced in lymphocytes from cancer patients,however the mRNA expressions of perforin and granzyme B were increased in CIK induced by cytokines and monoclone antibody compared with their lymphocytes(P0.01).CONCLUSION: The SYBR Green I real-time fluorescence quantitative PCR is a useful method for the quantitative detection of NKG2D,perforin and granzyme B mRNA to investigate cellular immune function.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第11期1108-1110,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 云南省后备人才基金资助项目(2008Y003)
关键词 实时荧光定量PCR 细胞免疫 NKG2D 穿孔素 颗粒酶B real-time fluorescence quantitative PCR cellular immunology NKG2D perforin granzyme B
  • 相关文献

参考文献7

  • 1Morissette MC,Parent J,Milot J.Perforin,granzyme B,and FasL expression by peripheral blood T lymphocytes in emphysema[J].Respir Res,2007,8:62-72.
  • 2Waldhauer I,Steinle A.NK cells and cancer immunoanrveillance[J].Oncogene,2008,27:5932-5943.
  • 3Nishimura R,Baker J,Beilhack A,et al.In vivo trafficking and surviva] of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor aclivity[J].Blood,2008,112:2563 -2574.
  • 4Smyth MJ,Swann J,Kelly JM,et al.NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer[J].J Exp Med,2004,200:1325-1335.
  • 5Derveaux S,Vandesompele J,Hellemans J.How to do successful gene expression analysis using real-time PCR[J].Methods,2010,50:227-230.
  • 6Arjona A,Boyadjieva N,Sarkar DK.Circadian rhythms of granzyme B,perforin,IFN-gamma,and NK cell cytolytic activity in the spleen:effects of chronic ethanol[J].J Immunol,2004,172:2811-2817.
  • 7Johnson BJ,Costelloe EO,Fitzpatrick DR,et al.Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice[J].Proc Natl Acad Sci USA,2003,100:2657-2662.

同被引文献43

  • 1Bae DS, Hwang YK, Lee JK . Importance of NKG2D-NKG2D ligands interaction for eytolytie activity of natural killer cell [ J ]. Cell Immunol, 2012, 276(1/2) : 122-127.
  • 2Pievani A, Borleri G, Pende D, et al. Dual-functional capability of CD3^+ CD56^+ CIK ceils, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity [ J ]. Blood, 2011, 118(12) : 3301-3310.
  • 3Morisaki T, Onishi H, Koya N, et al. Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer ceils in hepatocellular carcinoma via the NKG2D-MICA/B system [ J ]. Anticancer Res, 2011, 31(7) : 2505-2510.
  • 4Huang B, Sikorski R, Sampath P, et al. Modulation of NKG2D- ligand cell surface expression enhances immune cell therapy of cancer [J]. J Immunother, 2011, 34(3) : 289-296.
  • 5Franceschetti M, Pievani A, Borleri G, et al. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxie T-EMRA lymphocytes [ J ]. Exp Hematol, 2009, 37 (5) : 616- 628.
  • 6Linn YC, Lau SK, Liu BH, et al. Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell [ J]. Immunology, 2009, 126(3) : 423-435.
  • 7Mesiano G, Todorovic M, Gammaitoni L, et al. Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors [ J ]. Expert Opin Biol Ther, 2012, 12(6) : 673-684.
  • 8Kim JS, Park YS, Kim JY, et al. Inhibition of human pancreatic tumor growth by cytokine-induced killer cells in nude mouse xeno- graft model [J]. Immune Netw, 2012, 12(6) : 247-252.
  • 9Thanendrarajan S, Kim Y, Schmidt-Wolf I. New adoptive immunotherapy strategies for solid tumours with CIK cells [ J ]. Expert Opin Biol Ther, 2012, 12(5) : 565-572.
  • 10Laport GG, Sheehan K, Baker J, et al. Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation [J]. Biol Blood Marrow Transplant, 2011, 17 ( 11 ) : 1679- 1687.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部